(SPP7) SPDR Barclays 7-10 U.S. - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Etf •
ISIN: IE00BYSZ5T81
U.S. Government Bonds, Treasury, Securities, Fixed Income, U.S. Dollars
Description: SPP7 SPDR Barclays 7-10 U.S.
URL: http://www.ssga.com Index: Morningstar US Govt Bd TR USD
Additional Sources for SPP7 ETF
SPP7 ETF Overview
| Market Cap in USD | 15m |
| Category | USD Government Bond |
| TER | 0.15% |
| IPO / Inception | 2016-02-17 |
SPP7 ETF Ratings
| Growth Rating | -36.8 |
| Fundamental | - |
| Dividend Rating | 67.4 |
| Rel. Strength | -0.32 |
| Analysts | - |
| Fair Price Momentum | 21.05 EUR |
| Fair Price DCF | - |
SPP7 Dividends
| Dividend Yield 12m | 3.79% |
| Yield on Cost 5y | 3.34% |
| Annual Growth 5y | 13.33% |
| Payout Consistency | 90.1% |
| Payout Ratio | % |
SPP7 Growth Ratios
| Growth Correlation 3m | -73.7% |
| Growth Correlation 12m | -27.2% |
| Growth Correlation 5y | -50.7% |
| CAGR 5y | -3.18% |
| CAGR/Max DD 5y | -0.19 |
| Sharpe Ratio 12m | -1.24 |
| Alpha | -7.47 |
| Beta | -0.105 |
| Volatility | 6.86% |
| Current Volume | 0.3k |
| Average Volume 20d | 0.2k |
| Stop Loss | 21.3 (-3.6%) |
What is the price of SPP7 shares?
As of July 09, 2025, the stock is trading at EUR 22.09 with a total of 271 shares traded.
Over the past week, the price has changed by -0.40%, over one month by -1.56%, over three months by -6.88% and over the past year by -3.60%.
As of July 09, 2025, the stock is trading at EUR 22.09 with a total of 271 shares traded.
Over the past week, the price has changed by -0.40%, over one month by -1.56%, over three months by -6.88% and over the past year by -3.60%.
Is SPDR Barclays 7-10 U.S. a good stock to buy?
Probably not. Based on ValueRay´s Analyses, SPDR Barclays 7-10 U.S. (XETRA:SPP7) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -36.82 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPP7 is around 21.05 EUR . This means that SPP7 is currently overvalued and has a potential downside of -4.71%.
Probably not. Based on ValueRay´s Analyses, SPDR Barclays 7-10 U.S. (XETRA:SPP7) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -36.82 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SPP7 is around 21.05 EUR . This means that SPP7 is currently overvalued and has a potential downside of -4.71%.
Is SPP7 a buy, sell or hold?
SPDR Barclays 7-10 U.S. has no consensus analysts rating.
SPDR Barclays 7-10 U.S. has no consensus analysts rating.
What are the forecasts for SPP7 share price target?
According to our own proprietary Forecast Model, SPP7 SPDR Barclays 7-10 U.S. will be worth about 22.7 in July 2026. The stock is currently trading at 22.09. This means that the stock has a potential upside of +2.9%.
According to our own proprietary Forecast Model, SPP7 SPDR Barclays 7-10 U.S. will be worth about 22.7 in July 2026. The stock is currently trading at 22.09. This means that the stock has a potential upside of +2.9%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.7 | 2.9% |